HIV testing among pregnant women with prenatal care in the United States: An analysis of the 2011-2017 National Survey of Family Growth

International Journal of STD & AIDS
Babayemi O OlakundeDaniel A Adeyinka

Abstract

Although there has been significant progress in reducing perinatal human immunodeficiency virus (HIV) transmission, the United States is yet to meet the proposed elimination goal of less than one infection per 100,000 live births. Failure to screen all pregnant women for HIV as recommended by the Centers for Disease Control and Prevention can result in missed opportunities for preventing vertical transmission of HIV with antiretroviral drugs. Using the 2011-2017 National Survey of Family Growth, this study examined HIV testing among pregnant women during prenatal care. We estimated the weighted proportion of self-reported HIV testing among women whose last pregnancy ended within 12 months prior to the interview. Logistic regression models were used to determine the factors associated with HIV testing. Of the 1566 women included in the study, 76.4% (95% confidence intervals [CI] = 72.8-80.0) reported receiving an HIV test during prenatal care. In the multivariable regression model, high school diploma (adjusted odds ratio [aOR] = 1.9, 95% CI = 1.1-3.1), two completed pregnancies (aOR = 1.7, 95% CI = 1.1-2.7), health insurance coverage in the last 12 months (aOR = 1.6, 95% CI = 1.0-2.6), Hispanic race/ethnicity (aOR = 2.8, 95% CI...Continue Reading

References

Jan 1, 1997·Journal of Clinical Epidemiology·P O'CampoM Barbacci
Mar 10, 2001·Public Health Reports·M I FernándezJ Moore
Aug 14, 2001·American Journal of Public Health·A LanskyM L Lindegren
Jan 6, 2004·Obstetrics and Gynecology·John E AndersonStephanie Sansom
May 4, 2006·American Journal of Public Health·Benjamin P LinasKenneth A Freedberg
Jun 14, 2006·Maternal and Child Health Journal·John E Anderson, Stephanie Sansom
Aug 21, 2008·Maternal and Child Health Journal·Jean M LawrenceWilliam J Towner
Nov 4, 2008·Pediatrics·UNKNOWN American Academy of Pediatrics Committee on Pediatric AIDS
Dec 11, 2008·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Andrew E PetrollSteven D Pinkerton
Aug 6, 2009·Journal of General Internal Medicine·Janet J MyersKathleen McNamara
Jan 12, 2010·Maternal and Child Health Journal·Kathrine R TanDenise J Jamieson
Feb 9, 2011·Maternal and Child Health Journal·Pamela Rothpletz-PugliaDeanne Samuels
May 5, 2011·JAMA : the Journal of the American Medical Association·Sarah Neff, Ronald Goldschmidt
Jan 24, 2013·PloS One·A D McNaghtenPatrick S Sullivan
Feb 5, 2013·BMC Public Health·Eric Y WongBryan P Baugh
Dec 30, 2016·Maternal and Child Health Journal·Kavita Shah Arora, Barbara Wilkinson
May 31, 2017·The International Journal of Health Planning and Management·Fabrizio BertRoberta Siliquini
Feb 28, 2018·Sexually Transmitted Diseases·Lauren F FitzHarrisEmilia H Koumans
Jul 5, 2018·International Journal of STD & AIDS·Emilia H KoumansSteven R Nesheim
Sep 29, 2018·Public Health Reports·Steven R NesheimKristen Mahle Gray
Nov 27, 2018·AIDS·Devasena GnanashanmugamElaine J Abrams
Feb 7, 2019·The Pediatric Infectious Disease Journal·Steven R NesheimMargaret A Lampe
Feb 8, 2019·JAMA : the Journal of the American Medical Association·Anthony S FauciBrett P Giroir

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.